GlobalTort

GlobalTort

The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy

Category Archives: Science

Subscribe to Science RSS Feed

Cells – as Recorders of Events

Posted in Cancer, Science
The molecular revolution continues, with continuing implications for improving our understanding of how external events effect our cells.  SAs part of that journey, a group of researchers recently used CRISPR to embed a video into DNA and then retrieve it from the DNA, as described in a July 12, 2017 article at Stat News.  Why?… Continue Reading

Ancient Product Liability and/or Prehistoric Risk Assessment? “Scientists recreate Californian Indian water bottles to study ancient exposure to chemicals”

Posted in Science
A recent article caught my eye as it in some ways bridges older and newer lines of thinking and living.  The article describes current researchers testing an old Indian bottle making process for risks related to the use of bitumen. The article is summarized in a June 23, article at Science Daily. The introduction explains… Continue Reading

Smoking, Epigenetics and Autism – Epigenetic Links?

Posted in Mass Tort Issues, Science
The ongoing revolution in molecular science will help answer fascinating questions, such as why is there is more materially more autism among granddaughters of smokers. The answers, in turn, could have profound effects on business practices and product liability litigation. An April 28, 2017 article at Science Daily outlines the question as to smoking and… Continue Reading

Jurors In Toxic Tort Litigation Take Genetics Seriously

Posted in Asbestos, Cancer, Litigation Industry, Mass Tort Issues, Science
In the shameless self-promotion department, another article on “omics” and torts. LAW360 kindly published this on February 21, 2017.  In my view, it’s critical for trial lawyers to get focused on a range of topics related to “omics” and toxic torts. Jurors In Toxic Tort Litigation Take Genetics Seriously Share us on: Law360, New York… Continue Reading

Biomarker Exposure Tests Will Revolutionize Toxic Torts (Shameless Self Promotion)

Posted in Asbestos, Litigation Industry, Mass Tort Issues, Science
A bit of shameless self promotion for me and colleagues at Innovative Science Solutions. This week brought us 15 seconds of “fame” through publication of a February 7, 2017 article in a widely read national legal publication known as LAW360. The article focuses on the molecular biology revolution moving slowly but steadily into litigation involving… Continue Reading

World Cancer Day 2017

Posted in Cancer, Science
It is World Cancer Day 2017. The many diseases we call “cancer” will kill tens of millions over the coming years. Every sentient person should demand more investment in research against the many diseases that kill or maim our lovers, spouses, children, and other loved ones. See the World Cancer Day web site for the… Continue Reading

Finding Cancer Very Early: Grail and Illumina Start Another Year with Another Notable Step Forward

Posted in Asbestos, Cancer, Litigation Industry, Science
One year ago, Illumina announced a stunning goal: find all cancers very early (stage 1 or 2) through use of massive computing power and artificial intelligence to find mutated cells circulating in a small blood sample. The lead backers of the effort are the world leader in gene sequencing (Illumina), Bill Gates and Jeff Bezos… Continue Reading

2017 May Bring an End to the US Federal Version of the Ancient Document Hearsay Exception

Posted in Asbestos, Comparative Law, Evidence, Litigation Industry, Mass Tort Issues, Science
2016 has been quite the year, and it looks as if 2017 could be quite the year. To close out this year, a link to Nathan Schactman’s December 28, 2016 blog article regarding the likelihood that 2017 will bring an end to the federal rule for the ancient document exception to the hearsay rule. The article… Continue Reading

“The Future is Now:” New Opportunities and Risks from New Science and Technology

Posted in Product Liability, Science
This week brings another example of how quickly science and technology are providing new opportunities and risks related to new products and/or liability risks.  Specifically, here’s a December 21, 2016 article from Weil explaining where things are going – quickly – on vehicles and technology as NHTSA tosses out proposed tules on vehicles being able… Continue Reading

ACI’s 22nd Asbestos Claims & Litigation Forum

Posted in Asbestos, Litigation Industry, Science
ACI’s 22nd Asbestos Claims & Litigation forum, January 12-13 at the Union League of Philadelphia, is an event where law, science, and medicine will intersect to provide practitioners with more clarity and certainty with respect to pressing issues in the asbestos litigation industry. Top reasons to join this year’s conference: 1.    New sessions have been… Continue Reading

Kudos to the Few Who Invest in Molecular Science and Will Be Most Able to Create a Positive Out of the EPA List Naming Asbestos as a Top 10 Candidate for a Complete Ban or other Action

Posted in Asbestos, Cancer, Litigation Industry, Science
It’s not been a good run of days for asbestos defendants and other current and former sellers of alleged toxins. Yesterday,  under the new TSCA legislation, EPA issued its required list of its top 10 substances to investigate for a possible ban or other action.  “Asbestos” made the top 1o list. Not crocidolite. Not amosite.… Continue Reading

Not a Surprise: Projected Asbestos Loss for Insurers Raised by 18% by A.M. Best

Posted in Asbestos, Cancer, Litigation Industry, Science
A projected 18% increase in insurance company asbestos losses was announced yesterday by A.M. Best. Some of us are not surprised. Indeed, over the last two years, some of us wrote and sold two different white papers that explained why insurer losses would be going up (here and here). The white papers, it appears, helped… Continue Reading

Asbestos, Science and the 2017 ACI Conference in Philadelphia

Posted in Asbestos, Cancer, Science
Science, law and mass torts are increasingly intersecting and driving change.  The cancer research and medical communities are currently at the height of their conferences and workshop seasons, with recently completed and upcoming cancer conferences all over the US and indeed the world. In 2017, the medical and scientific data from 2016 will increasingly move… Continue Reading

Peyton Manning, Multidisciplinary Teams, and $88 Million of New Talc Verdict Losses for Some Talc Defendants and Some Insurers

Posted in Asbestos, Cancer, Litigation Industry, Mass Tort Issues, Science
Last week brought $88 million of losses for insurers and others in “talc” verdicts. A recent talk by Peyton Manning to insurance executives highlights the need for multidisciplinary teams if insurers and others actually wish to have a more complete understanding of contingent risks, such as talc claims. Manning’s comments are described in an October… Continue Reading

Analysis of a Brake Lining Ruling: “California Appellate Court Upholds “Every Exposure” Theory”

Posted in Asbestos, Daubert type rulings, Science
A post from defense lawyers evaluates the March 2016 decision in Davis v. Honeywell Int’l Inc., 199 Cal.Rptr.3d 583 (Cal. Ct. App. 2016). Davis is a case arising from asbestos in brake linings allegedly causing mesothelioma; see this August 8, 2016 post at Beveridge & Diamond, by Daniel Krainin. In the Davis opinion, plaintiff’s expert offered… Continue Reading

ToxicoEpigenetics Workshop – November 2-4, 2016 – DC Area

Posted in Asbestos, Science
Why should mass tort stakeholders care about toxicoepigenetics?  The start of the explanation is provided in an article online here; it is a promotion for an upcoming workshop on toxicoepigenetics. The introduction is cogent: “Why should toxicologists and risk assessors care about epigenetics? According to Dana C. Dolinoy, PhD, University of Michigan School of Public Health,… Continue Reading

Better Diagnoses – Multidisciplinary Hospital Teams for Mesotheliomas – a UK Example

Posted in Asbestos, Science
An interesting open access paper in the BJM discusses the process of and some values of a hospital using a multidisciplinary team to evaluate cases of mesotheliomas during the 2014-15 time frame. In short, the process resulted in more accurate diagnoses without undue delay. Thanks to Laurie Kazan Allen for flagging the paper in a September… Continue Reading

An Old Reinsurance Joke About the Next Asbestos, and Ostrich Irony

Posted in Asbestos, Cancer, Litigation Industry, Science
A friend let me know the following humor appeared this week on The Insurance Insider, along with some praise for Praedicat and its compilation of data on “the next asbestos.” I certainly join in both the joke and the praise for Praedicat, which I’ve been praising – in public – since 2014. Ironically, the insurance… Continue Reading